At JDRF we’re leading the fight against type 1 diabetes by funding research to improve lives and cure the disease.
We drive innovation, demand action and stand with everyone facing life with type 1 diabetes (T1D).
Research is the key to destroy T1D
Australians have type 1 diabetes.
Has been invested in Australian research to-date.
Bi-partisan promise in 2019.
What is type 1 diabetes?
Type 1 diabetes (T1D) is a lifelong autoimmune disease that destroys the body’s ability to process sugar by attacking the beta cells in the pancreas that produce insulin. Insulin helps convert sugar into the fuel that our bodies need. Without insulin, sugar builds up in the bloodstream in life-threatening amounts. Since people with T1D cannot produce insulin naturally, they must take it either through multiple daily injections or from an insulin pump.More about T1D
Improving lives each day until a cure.
While we search for a cure we are working to improve the lives of millions of Australians impacted by T1D. We fast-track new treatments and technology, and advocate for financial support for those who need it most.
We’ve been part of every breakthrough in T1D care in the last 45 years.Our Research
What we've achieved so far...
In Government subsidies.
Fewer needles with our Insulin Pump Program.
Funding for the T1DCRN
Find out more about us!
About JDRF Australia?
JDRF is the leading supporter of type 1 diabetes research in the world. Our vision? A world without type 1 diabetes.
As the leading supporter of type 1 diabetes research globally, we’ve been part of every major breakthrough in T1D care in the past 45 years.
How you can get involved
Donate, volunteer, fundraise or advocate! However you choose to get involved, your contribution could help us create a world without T1D.
JDRF's Latest News
Report: Aussie adults with type 1 diabetes unable to access life-changing technology due to high cost
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]
T1D Research Roundup: March 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Monash University researchers crack the […]
COVID-19 Vaccines and T1D: Answering Your Questions
Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines beginning to be offered to people with T1D, we’ve gathered all the information you need to […]
Top 10 T1D Research Breakthroughs of 2020
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission to cure, treat and prevent T1D – including new insights into what causes the disease, some incredible results from prevention therapies, and the launch of […]
New clinical trial results: Hybrid closed-loop technology for adults with T1D
Results from a recently completed JDRF clinical trial have shown some big benefits to hybrid closed-loop technology. Published in the journal Diabetes Care, the results come from a trial led by Prof David O’Neal from the University of Melbourne and the Australian JDRF Closed-Loop Research Group. This study has been funded by JDRF through its […]
Research Roundup: 5 Top Stories from EASD Annual Meeting 2020
The European Association for the Study of Diabetes (EASD) annual meeting brings together the top researchers from around the world to discuss the latest findings in diabetes research. This year, the meeting took place virtually for the first time, and JDRF researchers from Australia took centre stage to share their exciting results. Here’s our roundup […]
The Australasian Diabetes Data Network (ADDN) appoints a new Medical Director
JDRF is pleased to announce the appointment of Prof Maria Craig in a new role as Medical Director of the Australasian Diabetes Data Network (ADDN). Prof Craig has a wealth of experience as a paediatric endocrinologist and clinical researcher, and has worked as a principal investigator on the ADDN project. In her new role as […]
The Research Pathway: Turning an Idea Into a T1D Breakthrough
You may have heard that getting a new T1D treatment or device to market can take around 12 to 15 years. This is because there’s a huge amount of work that must take place before that intervention can be approved as being safe for use – from laboratory research in cells, right through to large […]
T1D Research Roundup: August 2020
Every month, we round up the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: An old drug with a […]
I am interested in hearing more about…